Search research articles
Contact Us
Filters
Showing results (281-290 of 483) with videos related to
Page
of 49
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2015
Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry
Florian Kocher, Wolfgang Hilbe, Andreas Seeber, et al.
Journal of Clinical Medicine
|
September 2, 2020
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
Florian Huemer, Eckhard Klieser, Daniel Neureiter, et al.
Journal of Clinical Medicine
|
April 3, 2020
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry
Florian Huemer, Lukas Weiss, Peter Regitnig, et al.
Therapeutic Advances in Medical Oncology
|
October 7, 2021
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Moritz Müller, Florian Posch, Dominik Kiem, et al.
The Lancet. Haematology
|
March 26, 2021
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
Sarah Gillessen, Annette Plütschow, Michael Fuchs, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 13, 2021
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer
Konstantin Schlick, Steiner Markus, Florian Huemer, et al.
Research and Practice in Thrombosis and Haemostasis
|
October 18, 2024
Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study
Christian Herbert Burgmann, Ulrich J Sachs, Karolin Trautmann-Grill, et al.
Oncotarget
|
April 21, 2015
CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21
Sylvia Ganghammer, Evelyn Hutterer, Elisabeth Hinterseer, et al.
Annals of Hematology
|
June 5, 2018
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
Alexander Egle, Michael Steurer, Thomas Melchardt, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 27, 2024
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A
Christina Hart, Robert Klamroth, Ulrich J Sachs, et al.
Page
of 49
Search research articles
Search
Showing results (281-290 of 483) with videos related to
Sort By:
Page
of 49
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2015
Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry
Florian Kocher, Wolfgang Hilbe, Andreas Seeber, et al.
Journal of Clinical Medicine
|
September 2, 2020
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
Florian Huemer, Eckhard Klieser, Daniel Neureiter, et al.
Journal of Clinical Medicine
|
April 3, 2020
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry
Florian Huemer, Lukas Weiss, Peter Regitnig, et al.
Therapeutic Advances in Medical Oncology
|
October 7, 2021
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Moritz Müller, Florian Posch, Dominik Kiem, et al.
The Lancet. Haematology
|
March 26, 2021
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
Sarah Gillessen, Annette Plütschow, Michael Fuchs, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 13, 2021
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer
Konstantin Schlick, Steiner Markus, Florian Huemer, et al.
Research and Practice in Thrombosis and Haemostasis
|
October 18, 2024
Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study
Christian Herbert Burgmann, Ulrich J Sachs, Karolin Trautmann-Grill, et al.
Oncotarget
|
April 21, 2015
CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21
Sylvia Ganghammer, Evelyn Hutterer, Elisabeth Hinterseer, et al.
Annals of Hematology
|
June 5, 2018
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
Alexander Egle, Michael Steurer, Thomas Melchardt, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 27, 2024
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A
Christina Hart, Robert Klamroth, Ulrich J Sachs, et al.
Page
of 49